InterOcean Capital Group’s AstraZeneca AZN Stock Holding History

InterOcean Capital Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$278K	Sell	2,052 -58	-3%	-$7.68K	0.01%	400
2023 Q4	$284K	Hold	2,110	–	–	0.01%	378
2023 Q3	$286K	Sell	2,110 -412	-16%	-$56.3K	0.01%	354
2023 Q2	$361K	Buy	2,522 +22	+0.9%	+$3.24K	0.01%	328
2023 Q1	$347K	Sell	2,500 -392	-14%	-$52.7K	0.01%	302
2022 Q4	$392K	Sell	2,892 -261	-8%	-$32.7K	0.01%	296
2022 Q3	$346K	Buy	3,153 +801	+34%	+$102K	0.01%	283
2022 Q2	$311K	Buy	2,352 +127	+6%	+$16.7K	0.01%	324
2022 Q1	$295K	Buy	2,225 +276	+14%	+$33.1K	0.01%	217
2021 Q4	$227K	Buy	1,949 +50	+3%	+$5.88K	0.01%	239
2021 Q3	$228K	Hold	1,899	–	–	0.01%	223
2021 Q2	$227K	Sell	1,899 -155	-8%	-$17K	0.01%	229
2021 Q1	$204K	Hold	2,054	–	–	0.01%	232
2020 Q4	$205K	Buy	+2,054	New	+$218K	0.01%	217

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

InterOcean Capital Group's AZN Position: Q1 2024 in Review

InterOcean Capital Group reduced its AstraZeneca (AZN) stake by 2.7% in Q1 2024, selling an estimated $7.68K and leaving 2,052 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #400.

InterOcean Capital Group first reported a position in AZN in Q4 2020 and has held it in 14 quarters since. The position peaked at $392K in Q4 2022. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

InterOcean Capital Group held 2,052 shares of AstraZeneca worth $278K as of Q1 2024.
InterOcean Capital Group sold 58 AstraZeneca shares in Q1 2024, an estimated $7.68K.
AstraZeneca made up 0.01% of InterOcean Capital Group's portfolio in Q1 2024, its #400 holding.
InterOcean Capital Group first reported a position in AstraZeneca in Q4 2020 and has held it in 14 quarters since.
InterOcean Capital Group's AstraZeneca position peaked at $392K in Q4 2022.
1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.